indapamide has been researched along with Disease Exacerbation in 4 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mohammedi, K | 1 |
Woodward, M | 3 |
Zoungas, S | 2 |
Li, Q | 1 |
Harrap, S | 1 |
Patel, A | 2 |
Marre, M | 2 |
Chalmers, J | 3 |
Kengne, AP | 1 |
Travert, F | 1 |
Lievre, M | 1 |
Colagiuri, S | 1 |
Grobbee, DE | 1 |
Hamet, P | 1 |
Heller, S | 1 |
Neal, B | 1 |
Koya, D | 1 |
Hasegawa, Y | 1 |
Yamaguchi, T | 1 |
Omae, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation[NCT00145925] | Phase 3 | 11,140 participants (Actual) | Interventional | 2001-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 trials available for indapamide and Disease Exacerbation
Article | Year |
---|---|
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disea | 2016 |
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Asia; Australasia; Blood Glucose; Canad | 2011 |
[Lowering blood pressure and glucose reduces renal events in type 2 diabetes; ADVANCE study].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; D | 2010 |
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain; Cere | 2004 |